A recent peer-reviewed study investigated how plasma-derived extracellular vesicle (EV) cargo from an exosome-enriched fraction changes
with aging and how these age-dependent differences i
Renal cell carcinoma (RCC) is the most common type of kidney cancer and one of the most challenging to treat in advanced stages.
While localised tumors can often be treated with surgery, m
Following cancer treatment, lymph node macrophages induced IL-33, a cytokine known for its roles in immune homeostasis and inflammation.1,2
In tumor setting, however, IL-33 fuels immune su
In the rapidly evolving field of molecular diagnostics and precision medicine, exosomes and their cargo have emerged as critical disease biomarkers. These tiny extracellular vesicles, found in bodil
A new study published in Nature Communications
introduces a synthetic gene circuit designed to release biological drugs in sync with the body's circadian rhythm. Built to combat conditions like rheum
Pancreatic cancer (PC) is one of the most aggressive and challenging cancers to treat, accounting for a significant proportion of cancer-related deaths worldwide (Yang et al., 2024). With a five-yea
Colorectal cancer (CRC), also known as bowel cancer, is one of the most common cancers worldwide. Affecting the colon or rectum, it often begins as noncancerous growths called polyps, which can
Over the past few years, there has been a lot of talk and numerous studies published surrounding the relationship between the gut microbiota and overall human health. Recently, studies have shown an a
This month, we’re focusing on four recent articles that made use of Norgen’s technology to explore different aspects of nutrition. The first two papers investigate the effect of nutritional intervent
March is Multiple Myeloma Month, which aims to raise awareness about this blood cancer that affects 1 in 100 American men (1/130 women).1
Multiple Myeloma cannot be cured, however, treatm